| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lin,Yu-Long | Chairman | 2.36% | |
| Huang,Min-Zhu | Director | 0.00% | |
| Dong,Ze-Ping | Director | 0.00% | |
| Yang,Yan-Chao | Director | 0.80% | MO SEN CAPITAL INVESTMENT LTD. |
| Zhao,Meng-Yan | Director | 0.23% | |
| Lu,Wei-Hua | Director | 0.71% | |
| Yang,Jun-Hong | Independent Director | 0.00% | |
| Chen,Qi-Xiang | Independent Director | 0.00% | |
| Weng,Wei-Lun | Independent Director | 0.00% |
Change Company Name to MARX Biotech Co., Ltd.
2024/06/04
Change Capital to 1,000,000,000
2023/10/06
Change Person in Charge to Lin,Yu-Long
2023/02/23
Change Company Name to MARS BIOTECHNOLOGY CO., LTD. (FORMER NAME: MOSON INVESTMENT CO., LTD.)
2022/07/20
Change Company Name to MARX Biotech Co., Ltd.
2021/12/06
Change Capital to 200,000,000
2021/12/06
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 214,273 | 289,925 | 110,642 |
| Operating cost | 53,581 | 75,333 | 26,432 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 160,692 | 214,592 | 84,210 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 160,692 | 214,592 | 84,210 |
| Operating expenses | 207,156 | 231,481 | 83,312 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -46,464 | -16,889 | 898 |
| Non-operating income and expenses | -4,493 | 1,401 | 4,008 |
| Net profit (loss) before tax | -50,957 | -15,488 | 4,906 |
| Income tax expense (benefits) | 880 | -2,571 | 2,075 |
| Net profit (loss) of ongoing business for the current period | -51,837 | -12,917 | 2,831 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -51,837 | -12,917 | 2,831 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -51,837 | -12,917 | 2,831 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | - | - | - |
| Net cash inflows (outflows) from investing activities | - | - | - |
| Net cash inflow (outflow) from financing activities | - | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
| Beginning balance of cash and cash equivalents | - | - | - |
| Ending balance of cash and cash equivalents | - | - | - |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 350,403 | 343,043 | 96,068 |
| Non-current asset | 63,056 | 51,804 | 7,118 |
| Total asset | 413,459 | 394,847 | 103,186 |
| Current liability | 164,694 | 101,036 | 41,503 |
| Non-current liability | 2,529 | 820 | 951 |
| Total liability | 167,223 | 101,856 | 42,454 |
| share capital | 124,514 | 124,514 | 40,802 |
| Equity - secruity token | - | - | - |
| capital reserve | 172,459 | 186,031 | 17,979 |
| retained earning | -50,737 | -17,554 | 1,951 |
| Other equity | - | - | - |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 246,236 | 292,991 | 60,732 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 0 | 1 | 0 |
